The reproducibility of repeat measures of airway inflammation in stable atopic asthma

被引:36
作者
Faul, JL
Demers, EA
Burke, CM
Poulter, LW
机构
[1] Royal Free Hosp, Sch Med, Dept Immunol, London NW3 2PE, England
[2] Stanford Univ, Div Pulm & Crit Care Med, Stanford, CA 94305 USA
[3] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA
[4] James Connolly Mem Hosp, Dept Resp Med, Dublin, Ireland
关键词
D O I
10.1164/ajrccm.160.5.9812027
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Measures of airway inflammation are increasingly being used as outcome measures in asthma intervention studies. Meaningful interpretation of observed changes in bronchial mucosal cell numbers should depend, in part, on the reproducibility of repeat measures over time. We wanted to investigate the reproducibility of immunopathologic and physiologic parameters after short and long measurement intervals. We therefore performed spirometry, bronchial provocation challenge, and fiberoptic bronchoscopy with endobronchial biopsy (always right upper lobe second-generation bronchus) at baseline, after 2 wk, and again after 8 wk on nine subjects with stable atopic asthma (receiving inhaled placebo and beta-agonist therapy only). Numbers of T cells, memory T cells (CD45Ro(+)), macrophages (CD68(+)), and eosinophils (EG1(+) and EG2(+)) on immunohistochemical stains of bronchial biopsies were quantified by computerized image analysis. Intraclass correlation coefficients (ICCs) of reproducibility were calculated for repeat measures of each parameter and a high ICC (greater than 0.6) was interpreted as "highly reproducible." Repeat measures of FEV1, FEF25-75%, and PC20 were highly reproducible after short (2-wk) and long (8-wk) intervals. Only repeat measures of EG2(+) had an ICC greater than 0.6 after 8 wk. Repeat measures of CD45Ro+, EG2+, and T cell numbers (but not CD68+ and EG1(+) cells) are highly reproducible and reliable parameters of asthmatic airway inflammation after a 2 wk interval.
引用
收藏
页码:1457 / 1461
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 1987, AM REV RESPIR DIS, V136, P225
[2]  
ARMITAGE P, 1996, BMJ-BRIT MED J, V313, P41
[3]   EFFICACY AND SAFETY OF INHALED CORTICOSTEROIDS IN ASTHMA - REPORT OF A WORKSHOP HELD IN EZE, FRANCE, OCTOBER 1992 [J].
BARNES, PJ ;
PEDERSEN, S .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :S1-S26
[4]   Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: A controlled study [J].
Burke, CM ;
Sreenan, S ;
Pathmakanthan, S ;
Patterson, J ;
Schmekel, B ;
Poulter, LW .
THORAX, 1996, 51 (10) :993-999
[5]   REPEATABILITY AND METHOD COMPARISON [J].
CHINN, S .
THORAX, 1991, 46 (06) :454-456
[6]   A COMPARATIVE-EVALUATION OF PROPOFOL AND MIDAZOLAM AS SEDATIVE AGENTS IN FIBEROPTIC BRONCHOSCOPY [J].
CLARKSON, K ;
POWER, CK ;
OCONNELL, F ;
PATHMAKANTHAN, S ;
BURKE, CM .
CHEST, 1993, 104 (04) :1029-1031
[7]   HISTAMINE DOSE-RESPONSE CURVES IN ASTHMA - REPRODUCIBILITY AND SENSITIVITY OF DIFFERENT INDEXES TO ASSESS RESPONSE [J].
DEHAUT, P ;
RACHIELE, A ;
MARTIN, RR ;
MALO, JL .
THORAX, 1983, 38 (07) :516-522
[8]   The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation [J].
Djukanovic, R ;
Homeyard, S ;
Gratziou, C ;
Madden, J ;
Walls, A ;
Montefort, S ;
Peroni, D ;
Polosa, R ;
Holgate, S ;
Howarth, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (03) :826-832
[9]   Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation [J].
Fahy, JV ;
Boushey, HA .
EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (06) :1240-1247
[10]   Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time [J].
Faul, JL ;
Leonard, CT ;
Burke, CM ;
Tormey, VJ ;
Poulter, LW .
THORAX, 1998, 53 (09) :753-761